A network meta-analysis of the long- and short-term efficacy of sleep medicines in adults and older adults

  title={A network meta-analysis of the long- and short-term efficacy of sleep medicines in adults and older adults},
  author={Lu Wang and Yundan Pan and Chunyan Ye and Lizhe Guo and Sumei Luo and Sisi Dai and Na Chen and Ente Wang},
  journal={Neuroscience \& Biobehavioral Reviews},
2 Citations

Figures and Tables from this paper

NSS_A_380465 1843..1855

  • 2022

Melatonin’s Benefits and Risks as a Therapy for Sleep Disturbances in the Elderly: Current Insights

Melatonin is both scientific and clinical evidence that melatonin is a safe drug for treating sleep disturbances in the elderly and an excellent anti-inflammatory agent, buffering free radicals, down-regulating proinflammatory cytokines, and reducing insulin resistance.



Pharmacotherapy of Insomnia

Medications with indications approved for insomnia treatment include benzodiazepine receptor agonists, a melatonin receptor agonist, a selective histamine receptor antagonist, and a dual orexin/hypocretin receptor antagonist.

Drugs for Insomnia beyond Benzodiazepines: Pharmacology, Clinical Applications, and Discovery

These drugs may improve sleep while successfully treating comorbid disorders, with a different side effect profile than the BZDs and Z-drugs.

Insomnia: Pharmacologic Therapy.

Insomnia accounts for more than 5.5 million visits to family physicians each year; behavioral interventions are the mainstay of treatment, pharmacologic therapy may be necessary for some patients, and sedating medications are not recommended unless they are used primarily to treat another condition.

Insomnia in the Older Adult.

Insomnia as a predictor of depression: a meta-analytic evaluation of longitudinal epidemiological studies.

Checking consistency in mixed treatment comparison meta‐analysis

A hierarchical Bayesian approach to MTC implemented using WinBUGS and R is taken and it is shown that both methods are useful in identifying potential inconsistencies in different types of network and that they illustrate how the direct and indirect evidence combine to produce the posterior MTC estimates of relative treatment effects.